Search Results - "CHETRITT, JEROME"

Intraepithelial CD94+ tumor-infiltrating lymphocytes in a context of HLA-E overexpression as a new immune checkpoint to predict prognosis in colorectal carcinomas by Bossard, Celine, Eugene, Juliette, Jouand, Nicolas, Dansette, Delphine, Leveque, Edouard, Podevin, Juliette, Matysiak, Tamara, Bezieau, Stephane, Chetritt, Jerome, Kerdraon, Olivier, Fourquier, Pierre, Thibaudeau, Emilie, Mosnier, Jean-François, Jarry, Anne, Gervois, Nadine

“…Abstract only e14592 Background: A better understanding of the immune-modulating interactions between tumor cells and immune cells underlying the balance…”
Get full text

Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer by Touchefeu, Yann, Provost-Dewitte, Marie, Lecomte, Thierry, Morel, Alain, Valo, Isabelle, Mosnier, Jean-François, Bossard, Céline, Eugène, Juliette, Duchalais, Emilie, Chetritt, Jérôme, Guyetant, Serge, Bézieau, Stéphane, Senellart, Hélène, Caulet, Morgane, Cauchin, Estelle, Matysiak-Budnik, Tamara

“…INTRODUCTIONThe assessment of risk factors of cancer recurrence in patients with stage II colon cancer (CC) is crucial. Our aim was to study the clinical,…”
Get full text

uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management by Luporsi, Elisabeth, Bellocq, Jean-Pierre, Barrière, Jérôme, Bonastre, Julia, Chetritt, Jérôme, Le Corroller, Anne-Gaëlle, de Cremoux, Patricia, Fina, Frédéric, Gauchez, Anne-Sophie, Lamy, Pierre-Jean, Martin, Pierre-Marie, Mazouni, Chafika, Peyrat, Jean-Philippe, Romieu, Gilles, Verdoni, Laetitia, Mazeau-Woynar, Valérie, Kassab-Chahmi, Diana

Get more information

uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management by Bellocq, Jean-Pierre, Luporsi, Elisabeth, Barrière, Jérôme, Bonastre, Julia, Chetritt, Jérôme, Le Corroller, Anne-Gaëlle, de Crémoux, Patricia, Fina, Frédéric, Gauchez, Anne-Sophie, Kassab-Chahmi, Diana, Lamy, Pierre-Jean, Martin, Pierre-Marie, Mazouni, Chafika, Peyrat, Jean-Philippe, Romieu, Gilles, Verdoni, Laetitia, Mazeau-Woynar, Valérie

“…Breast cancer prognosis and predictive biomarkers development would allow sparing some patients from chemotherapy or identifying patients for whom chemotherapy…”
Get more information

The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression by Eugène, Juliette, Jouand, Nicolas, Ducoin, Kathleen, Dansette, Delphine, Oger, Romain, Deleine, Cécile, Leveque, Edouard, Meurette, Guillaume, Podevin, Juliette, Matysiak, Tamara, Bennouna, Jaafar, Bezieau, Stéphane, Volteau, Christelle, Thomas, Wassila El Alami, Chetritt, Jerôme, Kerdraon, Olivier, Fourquier, Pierre, Thibaudeau, Emilie, Dumont, Frédéric, Mosnier, Jean-François, Toquet, Claire, Jarry, Anne, Gervois, Nadine, Bossard, Céline

“…We previously demonstrated that HLA-E/β2m overexpression by tumor cells in colorectal cancers is associated with an unfavorable prognosis. However, the…”
Get full text

Lethal Hepatitis After Gene Transfer of IL-4 in the Liver Is Independent of Immune Responses and Dependent on Apoptosis of Hepatocytes: A Rodent Model of IL-4-Induced Hepatitis by Guillot, Cecile, Coathalem, Helene, Chetritt, Jerome, David, Anne, Lowenstein, Pedro, Gilbert, Emmanuelle, Tesson, Laurent, van Rooijen, Nico, Cuturi, Maria Cristina, Soulillou, Jean-Paul, Anegon, Ignacio

“…The putative role of IL-4 in human and animal models of hepatitis has not yet been directly determined. We now report that direct expression of IL-4 in the…”
Get full text

Pathology of the Central Nervous System in Chester-Erdheim Disease: Report of Three Cases by ADLE-BIASSETTE, HOMA, CHETRITT, JEROME, BERGEMER-FOUQUET, ANNE MARIE, WECHSLER, JANINE, MUSSINI, JEAN MARIE, GRAY, FRANCOISE

“…Chester-Erdheim disease is a rare form of non-Langerhans cell histiocytosis consisting of disseminated xanthogranulomatous infiltration and fibrosis that…”
Get full text

The density of Tbet+ tumor-infiltrating T lymphocytes reflects an effective and druggable preexisting adaptive antitumor immune response in colorectal cancer, irrespective of the microsatellite status by Ott, Eva, Bilonda, Linda, Dansette, Delphine, Deleine, Cécile, Duchalais, Emilie, Podevin, Juliette, Volteau, Christelle, Bennouna, Jaafar, Touchefeu, Yann, Fourquier, Pierre, El Alami Thomas, Wassila, Chetritt, Jérome, Bezieau, Stéphane, Denis, Marc, Toquet, Claire, Mosnier, Jean-François, Jarry, Anne, Bossard, Céline

“…Purpose: The recent success of anti-PD1 antibody in metastatic colorectal cancer (CRC) patients with microsatellite instability (MSI), known to be associated…”
Get full text

Abstract 4061: The inflammasome of tumor cells modulates the biology of tumor-infiltrating T lymphocytes in colorectal cancer by Bilonda, Linda, Dansette, Delphine, Deleine, Cecile, Oger, Romain, Jouand, Nicolas, Podevin, Juliette, Fourquier, Pierre, Thibaudeau, Emilie, Chetritt, Jerome, Mosnier, Jean-François, Bossard, Celine, Gervois, Nadine, Jarry, Anne

“…Abstract In colorectal cancer (CRC), little is known about mechanisms by which tumor cells can influence the biology of Tumor Infiltrating T lymphocytes (TILs)…”
Get full text

Role of the inflammasome of tumor cells in modulating the biology of Tumor Infiltrating T lymphocytes (TILs) in colorectal cancer by Jarry, Anne, Ouairy, Adrien, Dansette, Delphine, Deleine, Cécile, Jouand, Nicolas, Oger, Romain, Podevin, Juliette, Fourquier, Pierre, Thibaudeau, Emilie, Chetritt, Jerome, Mosnier, Jean-François, Gervois, Nadine, Bossard, Celine

“…Abstract only e23087 Background: In colorectal cancer (CRC), little is known about mechanisms by which tumor cells can influence the phenotype and biology of…”
Get full text

Evolution of HER2 testing practices in breast cancer in France from 2005 to 2015: Results of the PartenHER national survey by Penault-Llorca, Frederique Madeleine, Chetritt, Jerome, Poulet, Bruno, Chenard, Marie-Pierre, Lacroix-Triki, Magali, Arnould, Laurent, mac Grogan, Gaetan, Bellocq, Jean-Pierre

“…Abstract only…”
Get full text

Abstract LB-142: CD94/NKG2A+ tumor-infiltrating lymphocytes in a context of HLA-E overexpression could be a promising new druggable inhibitory immune checkpoint in colorectal adenocarcinomas by EUGENE, Juliette, JOUAND, Nicolas, DANSETTE, Delphine, MEURETTE, Guillaume, Podevin, Juliette, MATYSIAK, Tamara, BEZIEAU, Stephane, VOLTEAU, Christelle, THOMAS, Wassila EL ALAMI, CHETRITT, Jerome, KERDRAON, Olivier, Fourquier, Pierre, THIBAUDEAU, Emilie, DUMONT, Frederic, MOSNIER, Jean-Francois, TOQUET, Claire, JARRY, Anne, GERVOIS, Nadine, Bossard, Celine

“…Abstract Background. We have previously demonstrated that overexpression of the human MHC class Ib molecule - HLA-E/β2 microglobulin (β2m) - by tumor cells in…”
Get full text

Factors influencing HER2 positivity in breast cancer according to statistical modeling and data mining techniques based on a real-world national database: HER-France by Chenard, Marie-Pierre, Anger, Eric, Bizollon, Marie-Helene, Chetritt, Jerome, Cutuli, Francesco Bruno, Kapfer, Jean, Lacroix, Magali, Lefebvre, Catherine, Lefort, Eve, mac Grogan, Gaetan, Palasse, Julien, Petit, Thomas, Poulet, Bruno, Rouleau, Vincent, Watkin, Emmanuel, Fetique, Dominique, Pau, David, Bellocq, Jean-Pierre

“…Abstract only…”
Get full text

Checking HER2 rates in breast cancer: A 4 year-experience with a nationwide database containing 105,717 records—HER-France by Chenard, Marie-Pierre, Anger, Eric, Bizollon, Marie-Helene, Chetritt, Jerome, Kapfer, Jean, Lacroix, Magali, Lefebvre, Catherine, Lefort, Eve, Luporsi-Gely, Elisabeth, mac Grogan, Gaetan, Palasse, Julien, Petit, Thomas, Poulet, Bruno, Rouleau, Vincent, Watkin, Emmanuel, Egele, Caroline, Bellocq, Jean-Pierre

“…Abstract only…”
Get full text

Risk score stratification of cutaneous melanomas based on whole slide images using deep learning by Bossard, Céline, Salhi, Yahia, Quereux, Gaelle, Khammari, Amir, Salhi, Sanae, Lavoine, Eric, Chetritt, Jérôme

“…e21573 Background: Predictive and prognostic biomarkers represent the cornerstone of clinical oncology. Improving the prognostication of melanoma is needed to…”
Get full text

Evaluation of AI-assisted HER2 scoring in breast carcinoma-stained whole-slide images by Thomas, Florian, Cormier, Bénédicte, Bossard, Céline, Poulet, Bruno, Guinaudeau, Emmanuelle, Salhi, Yahia, Chokri, Ilham, Jossic, Frédérique, Lambros, Laëtitia, De Pinieux, Isabelle, Thanguturi, Soum, Chetritt, Jérôme, Salhi, Sanae

“…e13029 Background: HER2 gene amplification occurs in 15% of invasive breast carcinomas. Given the exclusive effectiveness of HER2-targeted therapy in…”
Get full text

Sa1939 Clinical, Histological and Molecular Prognostic Factors for 3-Year Disease Free Survival in Patients With Stage II Colon Cancer by Touchefeu, Yann, Provost-Dewitte, Marie, Gounin, Sophie, Morel, Alain, Valo, Isabelle, Mosnier, Jean-François, Bossard, Céline, Eugene, Juliette, Chetritt, Jérôme, Bezieau, Stéphane, Senellart, Helène, Caulet, Morgane, Cauchin, Estelle, Lecomte, Thierry, Matysiak-Budnik, Tamara

Get full text

A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance by Josien, R, Douillard, P, Guillot, C, Müschen, M, Anegon, I, Chetritt, J, Menoret, S, Vignes, C, Soulillou, J P, Cuturi, M C

“…Donor-specific (DST) or nonspecific blood transfusions administered before transplantation can enhance survival of vascularized allografts both in humans and…”
Get full text

Chester-Erdheim disease: A neoplastic disorder by Chetritt, Jérôme, Paradis, Valérie, Dargere, Delphine, Adle-Biassette, Homa, Maurage, Claude Alain, Mussini, Jean Marie, Vital, Anne, Wechsler, Jeanine, Bedossa, Pierre

“…Chester-Erdheim disease is a rare non-langerhans cell histiocytosis characterized by a xanthomatous infiltration of foamy macrophages. The cause and…”
Get full text

uPA/PAI-1, Oncotype DX™, MammaPrint®. Valeurs pronostique et prédictive pour une utilité clinique dans la prise en charge du cancer du sein by Luporsi, Elisabeth, Bellocq, Jean-Pierre, Barrière, Jérôme, Bonastre, Julia, Chetritt, Jérôme, Le Corroller, Anne-Gaëlle, de Cremoux, Patricia, Fina, Frédéric, Gauchez, Anne-Sophie, Lamy, Pierre-Jean, Martin, Pierre-Marie, Mazouni, Chafika, Peyrat, Jean-Philippe, Romieu, Gilles, Verdoni, Laetitia, Mazeau-Woynar, Valérie, Kassab-Chahmi, Diana

“…Dans le cancer du sein, le développement des marqueurs biologiques pronostiques ou prédictifs a pour objectif de mieux identifier les patientes pour lesquelles…”
Get full text